Logo image of AMPX

AMPRIUS TECHNOLOGIES INC (AMPX) Stock Fundamental Analysis

NYSE:AMPX - New York Stock Exchange, Inc. - US03214Q1085 - Common Stock - Currency: USD

3.2  0 (0%)

After market: 3.24 +0.04 (+1.25%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMPX. AMPX was compared to 93 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for AMPX as it has an excellent financial health rating, but there are worries on the profitability. AMPX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AMPX had negative earnings in the past year.
In the past year AMPX has reported a negative cash flow from operations.
AMPX Yearly Net Income VS EBIT VS OCF VS FCFAMPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -34.13%, AMPX is doing worse than 65.22% of the companies in the same industry.
AMPX has a Return On Equity of -61.49%. This is comparable to the rest of the industry: AMPX outperforms 41.30% of its industry peers.
Industry RankSector Rank
ROA -34.13%
ROE -61.49%
ROIC N/A
ROA(3y)-36.13%
ROA(5y)N/A
ROE(3y)-52.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMPX Yearly ROA, ROE, ROICAMPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMPX Yearly Profit, Operating, Gross MarginsAMPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -100 -200 -300 -400

8

2. Health

2.1 Basic Checks

AMPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMPX has more shares outstanding than it did 1 year ago.
AMPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMPX Yearly Shares OutstandingAMPX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
AMPX Yearly Total Debt VS Total AssetsAMPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

AMPX has an Altman-Z score of 2.06. This is not the best score and indicates that AMPX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AMPX (2.06) is better than 64.13% of its industry peers.
There is no outstanding debt for AMPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.06
ROIC/WACCN/A
WACC10.33%
AMPX Yearly LT Debt VS Equity VS FCFAMPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 3.75 indicates that AMPX has no problem at all paying its short term obligations.
AMPX has a Current ratio of 3.75. This is amongst the best in the industry. AMPX outperforms 84.78% of its industry peers.
A Quick Ratio of 3.70 indicates that AMPX has no problem at all paying its short term obligations.
AMPX's Quick ratio of 3.70 is amongst the best of the industry. AMPX outperforms 89.13% of its industry peers.
Industry RankSector Rank
Current Ratio 3.75
Quick Ratio 3.7
AMPX Yearly Current Assets VS Current LiabilitesAMPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

7

3. Growth

3.1 Past

AMPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
Looking at the last year, AMPX shows a very strong growth in Revenue. The Revenue has grown by 105.28%.
Measured over the past years, AMPX shows a very strong growth in Revenue. The Revenue has been growing by 24.60% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)105.28%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%180.74%

3.2 Future

The Earnings Per Share is expected to grow by 17.22% on average over the next years. This is quite good.
The Revenue is expected to grow by 123.06% on average over the next years. This is a very strong growth
EPS Next Y-5.32%
EPS Next 2Y2.53%
EPS Next 3Y26.16%
EPS Next 5Y17.22%
Revenue Next Year164.82%
Revenue Next 2Y197.84%
Revenue Next 3Y213.9%
Revenue Next 5Y123.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMPX Yearly Revenue VS EstimatesAMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
AMPX Yearly EPS VS EstimatesAMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6 0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMPX. In the last year negative earnings were reported.
Also next year AMPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMPX Price Earnings VS Forward Price EarningsAMPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMPX Per share dataAMPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

AMPX's earnings are expected to grow with 26.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.53%
EPS Next 3Y26.16%

0

5. Dividend

5.1 Amount

No dividends for AMPX!.
Industry RankSector Rank
Dividend Yield N/A

AMPRIUS TECHNOLOGIES INC

NYSE:AMPX (2/4/2025, 8:26:30 PM)

After market: 3.24 +0.04 (+1.25%)

3.2

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners7.08%
Inst Owner Change0.76%
Ins Owners2.28%
Ins Owner Change0.16%
Market Cap353.82M
Analysts81.54
Price Target8.6 (168.75%)
Short Float %3.22%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.37%
Min EPS beat(2)4.45%
Max EPS beat(2)18.3%
EPS beat(4)3
Avg EPS beat(4)2.83%
Min EPS beat(4)-15.55%
Max EPS beat(4)18.3%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)186.75%
Min Revenue beat(2)43.21%
Max Revenue beat(2)330.3%
Revenue beat(4)4
Avg Revenue beat(4)148.86%
Min Revenue beat(4)9.73%
Max Revenue beat(4)330.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.61%
PT rev (3m)17.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)10.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)40.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.08
P/FCF N/A
P/OCF N/A
P/B 5.92
P/tB 5.92
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.08
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.13%
ROE -61.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.13%
ROA(5y)N/A
ROE(3y)-52.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 971.76%
Cap/Sales 193.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.75
Quick Ratio 3.7
Altman-Z 2.06
F-Score3
WACC10.33%
ROIC/WACCN/A
Cap/Depr(3y)370.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)83.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-5.32%
EPS Next 2Y2.53%
EPS Next 3Y26.16%
EPS Next 5Y17.22%
Revenue 1Y (TTM)105.28%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%180.74%
Revenue Next Year164.82%
Revenue Next 2Y197.84%
Revenue Next 3Y213.9%
Revenue Next 5Y123.06%
EBIT growth 1Y-114.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.88%
EBIT Next 3Y26.29%
EBIT Next 5Y38.7%
FCF growth 1Y-180.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.1%
OCF growth 3YN/A
OCF growth 5YN/A